Global Protein Drugs Market Research Report 2023

Publisher Name :
Date: 01-Feb-2023
No. of pages: 93
Inquire Before Buying

A type of drugs made of protein. These drugs usually have large molecular weight with proteincharacteristics.

Highlights

The global Protein Drugs market was valued at US$ 288760 million in 2022 and is anticipated to reach US$ 439710 million by 2029, witnessing a CAGR of 7.3% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Protein Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Protein Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Protein Drugs in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Protein Drugs include Eli Lilly, Abbott Laboratories, UCB Group, Schering-Plough Corporation, Genentech, Johnson&Johnson, Bristol-Myers Squibb, Novo Nordisk and Biogen Idec, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Protein Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Protein Drugs.

The Protein Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Protein Drugs market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Protein Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

- Eli Lilly

- Abbott Laboratories

- UCB Group

- Schering-Plough Corporation

- Genentech

- Johnson&Johnson

- Bristol-Myers Squibb

- Novo Nordisk

- Biogen Idec

- Dendreon Corporation

- Amgen Inc.

Segment by Type

- Antibody Drugs

- Peptide Hormones

- Blood Products

- Enzymes

Segment by Application

- Hospitals

- Clinics

- Other

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Protein Drugs companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Global Protein Drugs Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Protein Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Antibody Drugs
1.2.3 Peptide Hormones
1.2.4 Blood Products
1.2.5 Enzymes
1.3 Market by Application
1.3.1 Global Protein Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Protein Drugs Market Perspective (2018-2029)
2.2 Protein Drugs Growth Trends by Region
2.2.1 Global Protein Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Protein Drugs Historic Market Size by Region (2018-2023)
2.2.3 Protein Drugs Forecasted Market Size by Region (2024-2029)
2.3 Protein Drugs Market Dynamics
2.3.1 Protein Drugs Industry Trends
2.3.2 Protein Drugs Market Drivers
2.3.3 Protein Drugs Market Challenges
2.3.4 Protein Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Protein Drugs Players by Revenue
3.1.1 Global Top Protein Drugs Players by Revenue (2018-2023)
3.1.2 Global Protein Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Protein Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Protein Drugs Revenue
3.4 Global Protein Drugs Market Concentration Ratio
3.4.1 Global Protein Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Protein Drugs Revenue in 2022
3.5 Protein Drugs Key Players Head office and Area Served
3.6 Key Players Protein Drugs Product Solution and Service
3.7 Date of Enter into Protein Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Protein Drugs Breakdown Data by Type
4.1 Global Protein Drugs Historic Market Size by Type (2018-2023)
4.2 Global Protein Drugs Forecasted Market Size by Type (2024-2029)
5 Protein Drugs Breakdown Data by Application
5.1 Global Protein Drugs Historic Market Size by Application (2018-2023)
5.2 Global Protein Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Protein Drugs Market Size (2018-2029)
6.2 North America Protein Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Protein Drugs Market Size by Country (2018-2023)
6.4 North America Protein Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Protein Drugs Market Size (2018-2029)
7.2 Europe Protein Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Protein Drugs Market Size by Country (2018-2023)
7.4 Europe Protein Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Protein Drugs Market Size (2018-2029)
8.2 Asia-Pacific Protein Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Protein Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Protein Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Protein Drugs Market Size (2018-2029)
9.2 Latin America Protein Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Protein Drugs Market Size by Country (2018-2023)
9.4 Latin America Protein Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Protein Drugs Market Size (2018-2029)
10.2 Middle East & Africa Protein Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Protein Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Protein Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Protein Drugs Introduction
11.1.4 Eli Lilly Revenue in Protein Drugs Business (2018-2023)
11.1.5 Eli Lilly Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Protein Drugs Introduction
11.2.4 Abbott Laboratories Revenue in Protein Drugs Business (2018-2023)
11.2.5 Abbott Laboratories Recent Development
11.3 UCB Group
11.3.1 UCB Group Company Detail
11.3.2 UCB Group Business Overview
11.3.3 UCB Group Protein Drugs Introduction
11.3.4 UCB Group Revenue in Protein Drugs Business (2018-2023)
11.3.5 UCB Group Recent Development
11.4 Schering-Plough Corporation
11.4.1 Schering-Plough Corporation Company Detail
11.4.2 Schering-Plough Corporation Business Overview
11.4.3 Schering-Plough Corporation Protein Drugs Introduction
11.4.4 Schering-Plough Corporation Revenue in Protein Drugs Business (2018-2023)
11.4.5 Schering-Plough Corporation Recent Development
11.5 Genentech
11.5.1 Genentech Company Detail
11.5.2 Genentech Business Overview
11.5.3 Genentech Protein Drugs Introduction
11.5.4 Genentech Revenue in Protein Drugs Business (2018-2023)
11.5.5 Genentech Recent Development
11.6 Johnson?Johnson
11.6.1 Johnson?Johnson Company Detail
11.6.2 Johnson?Johnson Business Overview
11.6.3 Johnson?Johnson Protein Drugs Introduction
11.6.4 Johnson?Johnson Revenue in Protein Drugs Business (2018-2023)
11.6.5 Johnson?Johnson Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Detail
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Protein Drugs Introduction
11.7.4 Bristol-Myers Squibb Revenue in Protein Drugs Business (2018-2023)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Novo Nordisk
11.8.1 Novo Nordisk Company Detail
11.8.2 Novo Nordisk Business Overview
11.8.3 Novo Nordisk Protein Drugs Introduction
11.8.4 Novo Nordisk Revenue in Protein Drugs Business (2018-2023)
11.8.5 Novo Nordisk Recent Development
11.9 Biogen Idec
11.9.1 Biogen Idec Company Detail
11.9.2 Biogen Idec Business Overview
11.9.3 Biogen Idec Protein Drugs Introduction
11.9.4 Biogen Idec Revenue in Protein Drugs Business (2018-2023)
11.9.5 Biogen Idec Recent Development
11.10 Dendreon Corporation
11.10.1 Dendreon Corporation Company Detail
11.10.2 Dendreon Corporation Business Overview
11.10.3 Dendreon Corporation Protein Drugs Introduction
11.10.4 Dendreon Corporation Revenue in Protein Drugs Business (2018-2023)
11.10.5 Dendreon Corporation Recent Development
11.11 Amgen Inc.
11.11.1 Amgen Inc. Company Detail
11.11.2 Amgen Inc. Business Overview
11.11.3 Amgen Inc. Protein Drugs Introduction
11.11.4 Amgen Inc. Revenue in Protein Drugs Business (2018-2023)
11.11.5 Amgen Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Protein Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Antibody Drugs
Table 3. Key Players of Peptide Hormones
Table 4. Key Players of Blood Products
Table 5. Key Players of Enzymes
Table 6. Global Protein Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Protein Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Protein Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Protein Drugs Market Share by Region (2018-2023)
Table 10. Global Protein Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Protein Drugs Market Share by Region (2024-2029)
Table 12. Protein Drugs Market Trends
Table 13. Protein Drugs Market Drivers
Table 14. Protein Drugs Market Challenges
Table 15. Protein Drugs Market Restraints
Table 16. Global Protein Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Protein Drugs Market Share by Players (2018-2023)
Table 18. Global Top Protein Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Protein Drugs as of 2022)
Table 19. Ranking of Global Top Protein Drugs Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Protein Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Protein Drugs Product Solution and Service
Table 23. Date of Enter into Protein Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Protein Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Protein Drugs Revenue Market Share by Type (2018-2023)
Table 27. Global Protein Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Protein Drugs Revenue Market Share by Type (2024-2029)
Table 29. Global Protein Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Protein Drugs Revenue Market Share by Application (2018-2023)
Table 31. Global Protein Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Protein Drugs Revenue Market Share by Application (2024-2029)
Table 33. North America Protein Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Protein Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Protein Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Protein Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Protein Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Protein Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Protein Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Protein Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Protein Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Protein Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Protein Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Protein Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Protein Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Protein Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Protein Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 48. Eli Lilly Company Detail
Table 49. Eli Lilly Business Overview
Table 50. Eli Lilly Protein Drugs Product
Table 51. Eli Lilly Revenue in Protein Drugs Business (2018-2023) & (US$ Million)
Table 52. Eli Lilly Recent Development
Table 53. Abbott Laboratories Company Detail
Table 54. Abbott Laboratories Business Overview
Table 55. Abbott Laboratories Protein Drugs Product
Table 56. Abbott Laboratories Revenue in Protein Drugs Business (2018-2023) & (US$ Million)
Table 57. Abbott Laboratories Recent Development
Table 58. UCB Group Company Detail
Table 59. UCB Group Business Overview
Table 60. UCB Group Protein Drugs Product
Table 61. UCB Group Revenue in Protein Drugs Business (2018-2023) & (US$ Million)
Table 62. UCB Group Recent Development
Table 63. Schering-Plough Corporation Company Detail
Table 64. Schering-Plough Corporation Business Overview
Table 65. Schering-Plough Corporation Protein Drugs Product
Table 66. Schering-Plough Corporation Revenue in Protein Drugs Business (2018-2023) & (US$ Million)
Table 67. Schering-Plough Corporation Recent Development
Table 68. Genentech Company Detail
Table 69. Genentech Business Overview
Table 70. Genentech Protein Drugs Product
Table 71. Genentech Revenue in Protein Drugs Business (2018-2023) & (US$ Million)
Table 72. Genentech Recent Development
Table 73. Johnson?Johnson Company Detail
Table 74. Johnson?Johnson Business Overview
Table 75. Johnson?Johnson Protein Drugs Product
Table 76. Johnson?Johnson Revenue in Protein Drugs Business (2018-2023) & (US$ Million)
Table 77. Johnson?Johnson Recent Development
Table 78. Bristol-Myers Squibb Company Detail
Table 79. Bristol-Myers Squibb Business Overview
Table 80. Bristol-Myers Squibb Protein Drugs Product
Table 81. Bristol-Myers Squibb Revenue in Protein Drugs Business (2018-2023) & (US$ Million)
Table 82. Bristol-Myers Squibb Recent Development
Table 83. Novo Nordisk Company Detail
Table 84. Novo Nordisk Business Overview
Table 85. Novo Nordisk Protein Drugs Product
Table 86. Novo Nordisk Revenue in Protein Drugs Business (2018-2023) & (US$ Million)
Table 87. Novo Nordisk Recent Development
Table 88. Biogen Idec Company Detail
Table 89. Biogen Idec Business Overview
Table 90. Biogen Idec Protein Drugs Product
Table 91. Biogen Idec Revenue in Protein Drugs Business (2018-2023) & (US$ Million)
Table 92. Biogen Idec Recent Development
Table 93. Dendreon Corporation Company Detail
Table 94. Dendreon Corporation Business Overview
Table 95. Dendreon Corporation Protein Drugs Product
Table 96. Dendreon Corporation Revenue in Protein Drugs Business (2018-2023) & (US$ Million)
Table 97. Dendreon Corporation Recent Development
Table 98. Amgen Inc. Company Detail
Table 99. Amgen Inc. Business Overview
Table 100. Amgen Inc. Protein Drugs Product
Table 101. Amgen Inc. Revenue in Protein Drugs Business (2018-2023) & (US$ Million)
Table 102. Amgen Inc. Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Protein Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Protein Drugs Market Share by Type: 2022 VS 2029
Figure 3. Antibody Drugs Features
Figure 4. Peptide Hormones Features
Figure 5. Blood Products Features
Figure 6. Enzymes Features
Figure 7. Global Protein Drugs Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Protein Drugs Market Share by Application: 2022 VS 2029
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Other Case Studies
Figure 12. Protein Drugs Report Years Considered
Figure 13. Global Protein Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Protein Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Protein Drugs Market Share by Region: 2022 VS 2029
Figure 16. Global Protein Drugs Market Share by Players in 2022
Figure 17. Global Top Protein Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Protein Drugs as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Protein Drugs Revenue in 2022
Figure 19. North America Protein Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Protein Drugs Market Share by Country (2018-2029)
Figure 21. United States Protein Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Protein Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Protein Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Protein Drugs Market Share by Country (2018-2029)
Figure 25. Germany Protein Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Protein Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Protein Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Protein Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Protein Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Protein Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Protein Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Protein Drugs Market Share by Region (2018-2029)
Figure 33. China Protein Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Protein Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Protein Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Protein Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Protein Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Protein Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Protein Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Protein Drugs Market Share by Country (2018-2029)
Figure 41. Mexico Protein Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Protein Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Protein Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Protein Drugs Market Share by Country (2018-2029)
Figure 45. Turkey Protein Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Protein Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Eli Lilly Revenue Growth Rate in Protein Drugs Business (2018-2023)
Figure 48. Abbott Laboratories Revenue Growth Rate in Protein Drugs Business (2018-2023)
Figure 49. UCB Group Revenue Growth Rate in Protein Drugs Business (2018-2023)
Figure 50. Schering-Plough Corporation Revenue Growth Rate in Protein Drugs Business (2018-2023)
Figure 51. Genentech Revenue Growth Rate in Protein Drugs Business (2018-2023)
Figure 52. Johnson?Johnson Revenue Growth Rate in Protein Drugs Business (2018-2023)
Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Protein Drugs Business (2018-2023)
Figure 54. Novo Nordisk Revenue Growth Rate in Protein Drugs Business (2018-2023)
Figure 55. Biogen Idec Revenue Growth Rate in Protein Drugs Business (2018-2023)
Figure 56. Dendreon Corporation Revenue Growth Rate in Protein Drugs Business (2018-2023)
Figure 57. Amgen Inc. Revenue Growth Rate in Protein Drugs Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs